Preserving function and long-term patency of dialysis access

Annals of the Royal College of Surgeons of England

Volumn 81, Issue 5, 1999, Pages 339-342

  Akoh, J A ^a   Hakim, N S ^a  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS FISTULA; COLOR ULTRASOUND FLOWMETRY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT; SHORT SURVEY; STENOSIS; SURVIVAL RATE; THROMBOSIS; TIME; UNITED STATES; VASCULAR ACCESS;

ARTERIOVENOUS SHUNT, SURGICAL; CATHETERS, INDWELLING; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; VASCULAR PATENCY;

EID: 0032821832     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (31)

1. NIH. US Renal Data System: USRDS 1998 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1998.
2. Fan P-Y, Schwab SJ. Vascular access: concepts for the 1990s. J Am Soc Nephrol 1992; 3: 1-11.
3. Hirth RA, Turenne MN, Woods JD, Young EW, Port FK, Pauly MV et al. Predictors of type of vascular access in haemodialysis patients. JAMA 1996; 276: 1303-8.
4. Chazan JA, London MR, Pono LM. Long-term survival of vascular access in a large chronic haemodialysis population. Nephron 1995; 69: 228-33.
5. Seghal AR, Snow RJ, Singer ME, Amini SB, DeOreo PB, Silver MR et al. Barriers to adequate delivery of haemodialysis. Am J Kidney Dis 1998; 31: 593-601.
6. Held PJ, Carroll CE, Liska DW, Turenne MN, Pork FK. Haemodialysis therapy in the United States: what is the dose and does it matter? Am J Kidney Dis 1994; 24: 974-80.
7. Palder SB, Kirkman RL, Whittemore AD, Hakim RM, Lazarus JM, Tilney NL. Vascular access for haemodialysis. Patency rates and results of revision. Ann Surg 1985; 202: 235-9.
8. Winsett OE, Wolma FJ. Complications of vascular access for haemodialysis. South Med J 1985; 78: 513-7.
9. Windus DW. Permanent vascular access: a nephrologist's view. Am J Kidney Dis 1993; 21: 457-71.
10. Butterly DW. A quality improvement program for haemodialysis vascular access. Adv Ren Replace Ther 1994; 1: 163-6.
11. Windus DW, Audrain J, Vanderson R, Jendrisak MD, Picus D, Delmez JA. Optimization of high-efficiency haemodialysis by detection and correction of fistula dysfunction. Kidney Int 1990; 38: 337-11.
12. Depner TA. Techniques for prospective detection of venous stenosis. Adv Ren Replace Ther 1994; 1: 119-30.
13. Sands JJ, Miranda CL. Prolongation of haemodialysis access survival with elective revision. Clin Nephrol 1995; 44: 329-33.
14. Schwab SJ, Raymond JR, Saeed M, Newman GE, Dennis PA, Bollinger RR. Prevention of haemodialysis fistula thrombosis. Early detection of venous stenosis. Kidney Int 1989; 36: 707-11.
15. Sherman RA, Kapoian T. Recirculation, urea disequilibrium, and dialysis efficiency: peripheral arteriovenous versus central venovenous vascular access. Am J Kidney Dis 1997; 29: 479-89.
16. Collins DM, Lambert MB, Middleton JP, Proctor RK, Davidson CJ, Newman GE et al. Fistula dysfunction: effect on rapid haemodialysis. Kidney Int 1992; 41: 1292-6.
17. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-34.
18. Shohat J, Boner G. Adequacy of haemodialysis 1996. Nephron 1997; 76: 1-6.
19. Köksoy C, Kuzu A, Erden Î, Türkçapar AG, Düzgün Î, Anadol E. Predictive value of colour Doppler ultrasonography in detecting failure of vascular access grafts. Br J Surg 1995: 82: 50-2.
20. Bay WH, Henry ML, Lazarus JM, Lew NL, Ling J, Lowrie EG. Predicting haemodialysis access failure with colour flow Doppler ultrasound. Am J Nephrol 1998; 18: 296-304.
21. Gadallah MF, Paulson WD, Vickers B, Work J. Accuracy of Doppler ultrasound in diagnosing stenosis of haemodialysis arteriovenous access as compared with fistulography. Am J Kidney Dis 1998; 32: 273-7.
22. Cayco AV, Abu-Alfa AK, Mahnensmith RL, Perazella MA. Reduction in arteriovenous graft impairment: results of a vascular access surveillance protocol. Am J Kidney Dis 1998; 32: 302-6.
23. Burdick JF, Maley WR. Update on vascular access for haemodialysis. Adv Surgery 1997; 30: 223-32.
24. Reilly DT, Wood RFM, Bell PRF. Prospective study of dialysis fistulas: problem patients and their treatment. Br J Surg 1982; 69: 549-53.
25. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA. Haemodialysis vascular access morbidity in the United States. Kidney Int 1993; 43: 1091-6.
26. Muirhead N, Lanpacis A, Wong C. Erythropoietin for anaemia in haemodialysis patients: results of a maintenance study (The Canadian Erythropoietin Study Group). Nephrol Dial Transplant 1992; 7: 811-6.
27. Churchill DN, Muirhead N, Goldstein M, Posen G, Fay W, Beecroft ML et al Probability of thrombosis of vascular access among haemodialysis patients treated with recombinant human erythropoietin. J Am Soc Nephrol 1994; 4; 1809-13.
28. Harter HR, Burch JW, Majerus PW, Stanford N, Delmez JA, Anderson CB et al. Prevention of thrombosis in patients on haemodialysis by low-dose aspirin. N Engl J Med 1979; 301: 577-9.
29. Sreedhara R, Himmelfarb J, Lazarus JM, Hakim RM. Anti-platelet therapy in graft thrombosis: results of a prospective randomised double blind study. Kidney Int 1994; 45: 1477-83.
30. Hakim R, Himmelfarb J. Haemodialysis access failure: a call to action. Kidney Int 1998; 54: 1029-40.
31. NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 1997; 30: S150-91.